{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:16:33Z","timestamp":1792728993566,"version":"4.5.0"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T00:00:00Z","timestamp":1340755200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0038751","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T22:08:10Z","timestamp":1340834890000},"page":"e38751","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["IL-27 Regulates IL-18 Binding Protein in Skin Resident Cells"],"prefix":"10.1371","volume":"7","author":[{"given":"Miriam","family":"Wittmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Doble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Pfeilschifter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Werfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"M\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,6,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.4049\/jimmunol.172.4.2225","article-title":"WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27.","volume":"172","author":"S Pflanz","year":"2004","journal-title":"J Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.4049\/jimmunol.170.10.4886","article-title":"Cutting edge: role of IL-27\/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment.","volume":"170","author":"A Takeda","year":"2003","journal-title":"J Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells.","volume":"16","author":"S Pflanz","year":"2002","journal-title":"Immunity"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"15047","DOI":"10.1073\/pnas.2536517100","article-title":"IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms.","volume":"100","author":"S Lucas","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/10799900360708632","article-title":"IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells.","volume":"23","author":"L Hibbert","year":"2003","journal-title":"J Interferon Cytokine Res"},{"key":"ref6","article-title":"Zeitvogel J, Werfel T, Wittmann M (submitted) IL-27 acts as a Priming Signal for IL-23 but not IL-12 production on human antigen presenting cells."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaci.2009.04.026","article-title":"IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes.","volume":"124","author":"M Wittmann","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/jid.2009.349","article-title":"Possible roles of IL-27 in the pathogenesis of psoriasis.","volume":"130","author":"S Shibata","year":"2010","journal-title":"J Invest Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ni1376","article-title":"Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system.","volume":"7","author":"JS Stumhofer","year":"2006","journal-title":"Nat Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.4049\/jimmunol.177.8.5377","article-title":"Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism.","volume":"177","author":"T Yoshimura","year":"2006","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ni1375","article-title":"Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.","volume":"7","author":"M Batten","year":"2006","journal-title":"Nat Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/ard.2007.077537","article-title":"Amelioration of human lupus-like phenotypes in MRL\/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1).","volume":"67","author":"N Sugiyama","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.4049\/jimmunol.180.9.6325","article-title":"IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38.","volume":"180","author":"GD Kalliolias","year":"2008","journal-title":"J Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","article-title":"IL-1, IL-18, and IL-33 families of cytokines.","volume":"223","author":"WP Arend","year":"2008","journal-title":"Immunol Rev"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/ar1497","article-title":"Interleukin-18: a therapeutic target in rheumatoid arthritis?","volume":"7","author":"IB McInnes","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2004.07.012","article-title":"Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention.","volume":"500","author":"H Muhl","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.autrev.2009.03.003","article-title":"IL-18 and skin inflammation.","volume":"9","author":"M Wittmann","year":"2009","journal-title":"Autoimmun Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0952-7915(99)00051-5","article-title":"The role of IL-18 in innate immunity.","volume":"12","author":"S Akira","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1074-7613(00)80543-9","article-title":"Defective NK cell activity and Th1 response in IL-18-deficient mice.","volume":"8","author":"K Takeda","year":"1998","journal-title":"Immunity"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2249.2008.03772.x","article-title":"Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model.","volume":"154","author":"S Yamagata","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.0022-202X.2005.23715.x","article-title":"Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases.","volume":"124","author":"M Wittmann","year":"2005","journal-title":"J Invest Dermatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1468-3083.2003.00647.x","article-title":"Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: preliminary considerations.","volume":"17","author":"S Gangemi","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1002\/art.23868","article-title":"Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosus.","volume":"58","author":"D Wang","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref24","first-page":"210","article-title":"Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions.","volume":"15","author":"A Companjen","year":"2004","journal-title":"Eur Cytokine Netw"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1038\/sj.jid.5700922","article-title":"The activity of caspase-1 is increased in lesional psoriatic epidermis.","volume":"127","author":"C Johansen","year":"2007","journal-title":"J Invest Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s004030100240","article-title":"Expression of IL-18 in psoriasis.","volume":"293","author":"Y Ohta","year":"2001","journal-title":"Arch Dermatol Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1046\/j.1523-1747.1999.00750.x","article-title":"Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene.","volume":"113","author":"SM Naik","year":"1999","journal-title":"J Invest Dermatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1046\/j.1523-1747.2000.02003.x","article-title":"Expression of IL-18 in human keratinocytes.","volume":"114","author":"AR Companjen","year":"2000","journal-title":"J Invest Dermatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.4049\/jimmunol.171.12.6363","article-title":"Human dendritic cells express the IL-18R and are chemoattracted to IL-18.","volume":"171","author":"R Gutzmer","year":"2003","journal-title":"J Immunol"},{"key":"ref30","first-page":"626","article-title":"Regulation of interleukin-18 (IL-18) expression in keratinocytes (HaCaT): implications for early wound healing.","volume":"11","author":"H Kampfer","year":"2000","journal-title":"Eur Cytokine Netw"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virol.2004.02.027","article-title":"Identification of residues in an orthopoxvirus interleukin-18 binding protein involved in ligand binding and species specificity.","volume":"323","author":"DJ Esteban","year":"2004","journal-title":"Virology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1128\/JVI.77.18.9960-9968.2003","article-title":"Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity.","volume":"77","author":"PC Reading","year":"2003","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1073\/pnas.96.20.11537","article-title":"IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins.","volume":"96","author":"Y Xiang","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1128\/JVI.77.4.2623-2630.2003","article-title":"Molluscum contagiosum virus interleukin-18 (IL-18) binding protein is secreted as a full-length form that binds cell surface glycosaminoglycans through the C-terminal tail and a furin-cleaved form with only the IL-18 binding domain.","volume":"77","author":"Y Xiang","year":"2003","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4049\/jimmunol.167.1.497","article-title":"Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells.","volume":"167","author":"SJ Lee","year":"2001","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ki.2009.216","article-title":"IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis.","volume":"76","author":"AH Bani-Hani","year":"2009","journal-title":"Kidney Int"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"14765","DOI":"10.1073\/pnas.0706378104","article-title":"T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-gamma and IL-13 production.","volume":"104","author":"N Hayashi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2119\/molmed.2010.00028","article-title":"Overexpression of interleukin-18 aggravates cardiac fibrosis and diastolic dysfunction in fructose-fed rats.","volume":"16","author":"SS Xing","year":"2010","journal-title":"Mol Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"H76","DOI":"10.1152\/ajpheart.01285.2008","article-title":"IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice.","volume":"297","author":"Q Yu","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/eji.200636420","article-title":"IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.","volume":"37","author":"N Kanda","year":"2007","journal-title":"Eur J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1074-7613(00)80013-8","article-title":"Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response.","volume":"10","author":"D Novick","year":"1999","journal-title":"Immunity"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1073\/pnas.97.3.1190","article-title":"Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18.","volume":"97","author":"SH Kim","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1006\/bbrc.1999.2064","article-title":"Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells.","volume":"267","author":"H Muhl","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1086\/650314","article-title":"HIV-1 causes an imbalance in the production of interleukin-18 and its natural antagonist in HIV-infected individuals: implications for enhanced viral replication.","volume":"201","author":"A Iannello","year":"2010","journal-title":"J Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.4049\/jimmunol.167.12.7038","article-title":"Expression and release of IL-18 binding protein in response to IFN-gamma.","volume":"167","author":"J Paulukat","year":"2001","journal-title":"J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/rheumatology\/keg146","article-title":"Interferon-gamma induces expression of interleukin-18 binding protein in fibroblast-like synoviocytes.","volume":"42","author":"B Moller","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"16957","DOI":"10.1073\/pnas.262663399","article-title":"The promoter of IL-18 binding protein: activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT\/enhancer binding protein beta.","volume":"99","author":"V Hurgin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1111\/j.1582-4934.2008.00604.x","article-title":"Molecular mechanisms of IL-18BP regulation in DLD-1 cells: pivotal direct action of the STAT1\/GAS axis on the promoter level.","volume":"13","author":"M Bachmann","year":"2009","journal-title":"J Cell Mol Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.yjmcc.2011.09.022","article-title":"beta2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.","volume":"52","author":"DR Murray","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1365-2249.2002.01911.x","article-title":"Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients.","volume":"129","author":"A Kaser","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.tiv.2009.04.005","article-title":"Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens.","volume":"23","author":"E Corsini","year":"2009","journal-title":"Toxicol In Vitro"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.semnephrol.2006.09.013","article-title":"Interleukin-18 and the pathogenesis of inflammatory diseases.","volume":"27","author":"CA Dinarello","year":"2007","journal-title":"Semin Nephrol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.imlet.2004.06.011","article-title":"Increased expression of IL-18 in cutaneous graft-versus-host disease.","volume":"95","author":"HJ Park","year":"2004","journal-title":"Immunol Lett"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.autrev.2005.04.009","article-title":"Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18.","volume":"4","author":"N Calvani","year":"2005","journal-title":"Autoimmun Rev"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.autrev.2006.08.010","article-title":"Interleukin-18 in chronic joint diseases.","volume":"6","author":"AP Lotito","year":"2007","journal-title":"Autoimmun Rev"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10067-010-1386-6","article-title":"Expressions of IL-18 and its binding protein in peripheral blood leukocytes and kidney tissues of lupus nephritis patients.","volume":"29","author":"D Hu","year":"2010","journal-title":"Clin Rheumatol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jaut.2009.08.002","article-title":"High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein.","volume":"34","author":"D Novick","year":"2010","journal-title":"J Autoimmun"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1189\/jlb.0604352","article-title":"IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis.","volume":"83","author":"C Antonopoulos","year":"2008","journal-title":"J Leukoc Biol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1749-6632.2009.04742.x","article-title":"IL-18 activity in systemic lupus erythematosus.","volume":"1173","author":"F Favilli","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/A:1020600230977","article-title":"Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease.","volume":"22","author":"O Ludwiczek","year":"2002","journal-title":"J Clin Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1096\/fj.04-2426fje","article-title":"Evidence for altered interleukin 18 (IL)-18 pathway in human heart failure.","volume":"18","author":"Z Mallat","year":"2004","journal-title":"FASEB J"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"16006","DOI":"10.1074\/jbc.M611040200","article-title":"The interleukin-22\/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells.","volume":"282","author":"E Ziesche","year":"2007","journal-title":"J Biol Chem"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03191127","article-title":"Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis.","volume":"31","author":"PP Tak","year":"2006","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1684\/ecn.2011.0288","article-title":"IL-37: a new anti-inflammatory cytokine of the IL-1 family.","volume":"22","author":"D Boraschi","year":"2011","journal-title":"Eur Cytokine Netw"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity.","volume":"11","author":"MF Nold","year":"2010","journal-title":"Nat Immunol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1093\/nar\/gkp525","article-title":"Activation of interferon regulatory factor-3 via toll-like receptor 3 and immunomodulatory functions detected in A549 lung epithelial cells exposed to misplaced U1-snRNA.","volume":"37","author":"CD Sadik","year":"2009","journal-title":"Nucleic Acids Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0038751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T01:03:03Z","timestamp":1594342983000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0038751"}},"subtitle":[],"editor":[{"given":"Pierre","family":"Bob\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,27]]},"references-count":66,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0038751","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,27]]}}}